Clorox (NYSE:CLX – Get Free Report) had its target price cut by analysts at Citigroup from $115.00 to $110.00 in a report released on Wednesday, Marketbeat reports. The firm presently has a “neutral” rating on the stock. Citigroup’s price target would suggest a potential upside of 7.39% from the stock’s previous close.
Several other equities research analysts also recently commented on the company. Rothschild & Co Redburn set a $117.00 target price on Clorox in a report on Friday, February 13th. Barclays dropped their target price on Clorox from $109.00 to $102.00 and set an “underweight” rating on the stock in a research report on Tuesday. Weiss Ratings raised Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft dropped their target price on Clorox from $112.00 to $101.00 and set a “hold” rating on the stock in a research report on Monday, March 30th. Finally, UBS Group lowered their price objective on Clorox from $121.00 to $110.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. One analyst has rated the stock with a Buy rating, thirteen have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $115.13.
Read Our Latest Research Report on Clorox
Clorox Trading Down 0.5%
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the business earned $1.55 EPS. The company’s quarterly revenue was down .8% compared to the same quarter last year. Equities analysts predict that Clorox will post 7.15 earnings per share for the current year.
Institutional Trading of Clorox
Institutional investors have recently modified their holdings of the company. Center for Financial Planning Inc. acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $25,000. Vermillion & White Wealth Management Group LLC bought a new position in shares of Clorox during the 3rd quarter worth approximately $25,000. True Wealth Design LLC raised its position in Clorox by 1,020.0% in the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 204 shares during the last quarter. Root Financial Partners LLC bought a new position in Clorox in the 3rd quarter valued at $29,000. Finally, Darwin Wealth Management LLC bought a new position in Clorox in the 2nd quarter valued at $29,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Further Reading
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
